Search research articles
Contact Us
Filters
Showing results (331-340 of 363) with videos related to
Page
of 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
David S Hong, Nicole Concin, Ignace Vergote, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial
Matthew Tate, Christopher J R Illingworth, Gordon MacGregor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2022
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer
Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang, et al.
The Lancet. Oncology
|
February 16, 2023
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
Janet E Brown, Kara-Louise Royle, Walter Gregory, et al.
BJC Reports
|
March 27, 2025
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers
Peter Gallagher, Christian Rolfo, Elena Elez, et al.
Neuroimage. Clinical
|
April 28, 2020
Image acquisition and quality assurance in the Boston Adolescent Neuroimaging of Depression and Anxiety study
Viviana Siless, Nicholas A Hubbard, Robert Jones, et al.
Surgery
|
March 22, 2024
Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?
Rami Rhaiem, Adrien Duramé, Florian Primavesi, et al.
British Journal of Cancer
|
November 8, 2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology
Richard Phillips, Bristi Basu, Zohra Butt, et al.
Faraday Discussions
|
October 17, 2017
Supramolecular effects in self-assembled monolayers: general discussion
David Amabilino, Ioan Bâldea, James Batteas, et al.
Health Technology Assessment (Winchester, England)
|
September 9, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
Fiona Collinson, Kara-Louise Royle, Jayne Swain, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 363) with videos related to
Sort By:
Page
of 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
David S Hong, Nicole Concin, Ignace Vergote, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial
Matthew Tate, Christopher J R Illingworth, Gordon MacGregor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2022
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer
Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang, et al.
The Lancet. Oncology
|
February 16, 2023
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
Janet E Brown, Kara-Louise Royle, Walter Gregory, et al.
BJC Reports
|
March 27, 2025
A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers
Peter Gallagher, Christian Rolfo, Elena Elez, et al.
Neuroimage. Clinical
|
April 28, 2020
Image acquisition and quality assurance in the Boston Adolescent Neuroimaging of Depression and Anxiety study
Viviana Siless, Nicholas A Hubbard, Robert Jones, et al.
Surgery
|
March 22, 2024
Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?
Rami Rhaiem, Adrien Duramé, Florian Primavesi, et al.
British Journal of Cancer
|
November 8, 2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology
Richard Phillips, Bristi Basu, Zohra Butt, et al.
Faraday Discussions
|
October 17, 2017
Supramolecular effects in self-assembled monolayers: general discussion
David Amabilino, Ioan Bâldea, James Batteas, et al.
Health Technology Assessment (Winchester, England)
|
September 9, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
Fiona Collinson, Kara-Louise Royle, Jayne Swain, et al.
Page
of 37